Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Oncoimmunology. 2012 Jul 1;1(4):541-543.

A novel facet of tumor suppression by p53: Induction of tumor immunogenicity.

Author information

  • 1Department of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden.

Abstract

Pharmacological reactivation of the p53 tumor suppressor is a promising strategy for anti-cancer therapy due to its high potential to elicit apoptosis or growth arrest in cancer cells. Recently we uncovered the mechanism of activation of the innate immune response by p53 upon its activation by small molecules.

PMID:
22754780
[PubMed]
PMCID:
PMC3382884
Free PMC Article

Images from this publication.See all images (1)Free text

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk